Boiron SA (BOI) - Total Assets

Latest as of June 2025: €561.59 Million EUR ≈ $656.56 Million USD

Based on the latest financial reports, Boiron SA (BOI) holds total assets worth €561.59 Million EUR (≈ $656.56 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Boiron SA (BOI) net assets for net asset value and shareholders' equity analysis.

Boiron SA - Total Assets Trend (2001–2024)

This chart illustrates how Boiron SA's total assets have evolved over time, based on quarterly financial data.

Boiron SA - Asset Composition Analysis

Current Asset Composition (December 2024)

Boiron SA's total assets of €561.59 Million consist of 48.8% current assets and 51.2% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	11.2%
Accounts Receivable	€109.99 Million	19.1%
Inventory	€101.11 Million	17.5%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€29.27 Million	5.1%
Goodwill	€89.74 Million	15.6%

Asset Composition Trend (2001–2024)

This chart illustrates how Boiron SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Boiron SA (BOI) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Boiron SA's current assets represent 48.8% of total assets in 2024, a decrease from 57.7% in 2001.
Cash Position: Cash and equivalents constituted 11.2% of total assets in 2024, up from 9.5% in 2001.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 7.0% in 2001.
Asset Diversification: The largest asset category is accounts receivable at 19.1% of total assets.

Boiron SA Competitors by Total Assets

Key competitors of Boiron SA based on total assets are shown below.

Company	Country	Total Assets
Daihan Pharmaceutical Co.Ltd KQ:023910	Korea	₩344.02 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs525.46 Billion
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	China	CN¥56.56 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.75 Billion
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	China	CN¥7.26 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Zhejiang Cheng Yi Pharmaceutical Co Ltd SHG:603811	China	CN¥1.69 Billion
Hainan Honz Pharmaceutical Co SHE:300086	China	CN¥1.88 Billion

Boiron SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.39	2.25	2.27
Quick Ratio	1.46	1.37	1.84
Cash Ratio	0.00	0.00	0.00
Working Capital	€155.44 Million	€141.79 Million	€231.99 Million

Boiron SA - Advanced Valuation Insights

This section examines the relationship between Boiron SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.23
Latest Market Cap to Assets Ratio	0.79
Asset Growth Rate (YoY)	-2.4%
Total Assets	€576.33 Million
Market Capitalization	$456.63 Million USD

Valuation Analysis

Below Book Valuation: The market values Boiron SA's assets below their book value (0.79x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Boiron SA's assets decreased by 2.4% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Boiron SA (2001–2024)

The table below shows the annual total assets of Boiron SA from 2001 to 2024.

Year	Total Assets	Change
2024-12-31	€576.33 Million ≈ $673.79 Million	-2.35%
2023-12-31	€590.20 Million ≈ $690.01 Million	-25.24%
2022-12-31	€789.49 Million ≈ $923.00 Million	+2.44%
2021-12-31	€770.70 Million ≈ $901.03 Million	-1.42%
2020-12-31	€781.82 Million ≈ $914.03 Million	+2.29%
2019-12-31	€764.28 Million ≈ $893.53 Million	-0.36%
2018-12-31	€767.08 Million ≈ $896.79 Million	-4.16%
2017-12-31	€800.40 Million ≈ $935.76 Million	+6.01%
2016-12-31	€755.03 Million ≈ $882.71 Million	+8.57%
2015-12-31	€695.45 Million ≈ $813.05 Million	+3.87%
2014-12-31	€669.55 Million ≈ $782.77 Million	+0.29%
2013-12-31	€667.59 Million ≈ $780.48 Million	+15.24%
2012-12-31	€579.28 Million ≈ $677.24 Million	-1.42%
2011-12-31	€587.61 Million ≈ $686.97 Million	+5.24%
2010-12-31	€558.34 Million ≈ $652.76 Million	+6.98%
2009-12-31	€521.93 Million ≈ $610.20 Million	+12.65%
2008-12-31	€463.34 Million ≈ $541.70 Million	+8.16%
2007-12-31	€428.39 Million ≈ $500.83 Million	+3.96%
2006-12-31	€412.06 Million ≈ $481.74 Million	-3.56%
2005-12-31	€427.25 Million ≈ $499.50 Million	+57.65%
2004-12-31	€271.02 Million ≈ $316.85 Million	+9.29%
2003-12-31	€247.97 Million ≈ $289.91 Million	+7.47%
2002-12-31	€230.73 Million ≈ $269.74 Million	+12.08%
2001-12-31	€205.86 Million ≈ $240.67 Million	--

About Boiron SA

PA:BOI France Drug Manufacturers - Specialty & Generic

Market Cap

$556.17 Million

€475.73 Million EUR

Market Cap Rank

#13010 Global

#194 in France

Share Price

€27.40

Change (1 day)

+4.58%

52-Week Range

€20.90 - €31.70

All Time High

€59.48